Immune Checkpoint Molecules in Adrenocortical Carcinoma: Hope for Immunotherapy

Affiliations

Editorial

Enzo Lalli. J Clin Endocrinol Metab. 2024.

. 2024 Dec 18;110(1):e188-e189.

doi: 10.1210/clinem/dgae311.

¹ Institut de Pharmacologie Moléculaire et Cellulaire CNRS UMR7275, Inserm U1323, Université Côte d'Azur, 05650 Valbonne, France.

No abstract available

Comment on

Expression and Prognostic Relevance of PD-1, PD-L1, and CTLA-4 Immune Checkpoints in Adrenocortical Carcinoma.
Landwehr LS, Altieri B, Sbiera I, Remde H, Kircher S, Olabe J, Sbiera S, Kroiss M, Fassnacht M. Landwehr LS, et al. J Clin Endocrinol Metab. 2024 Aug 13;109(9):2325-2334. doi: 10.1210/clinem/dgae109. J Clin Endocrinol Metab. 2024. PMID: 38415841 Free PMC article.